Agency for Medical Innovations

A.M.I. – Agency for Medical Innovations is a company in Feldkirch, Austria. Registered as a company in late 1998 by a team from the medical device and engineering industries, it provides European surgeons with support in bringing product ideas to life. Its product areas include urology, coloproctology and urogynecology, with offerings such as the A.M.I. HAL system, the ATOMS system, and urogynecology products including EndoGYNious, ProGYNious, PelviGYNious and InGYNious.

In late 1998, a team of seasoned professionals from the medical device and engineering industries united to register A.M.I. as a company, aiming to provide European surgeons with swift, expert support in bringing product ideas to life. In 2000, the HAL method was introduced in Europe as a new, efficient and pain-free approach to treating hemorrhoidal disease with the A.M.I. HAL system; that year also saw the establishment of a sales branch in Germany, now A.M.I. Germany, and the acquisition of DUFOUR Medical S.A. in France, which paved the way for the future subsidiary A.M.I. France. In 2002, A.M.I. received the Innovation Award from the Province of Vorarlberg for its A.M.I. HAL System. In January 2004, the groundbreaking ceremony for the new company headquarters took place in Feldkirch, Austria, and by October of the same year the new "Innovation Office" was completed; A.M.I. was again honored with the Innovation Award from the Province of Vorarlberg, this time for its Anal Band implant for the treatment of Fecal Incontinence. In 2008, construction of the second extension, the "Innovation Facility", took place; the MediKids childcare center opened in November, offering on-site daycare for employees and the community; the A.M.I. Sales Branch opened in Marblehead, Massachusetts, establishing A.M.I.'s entry into the U.S. market; and the ATOMS system was introduced for the treatment of male urinary incontinence and officially published and launched into the market. In 2010, the BSC Mesh and ATOMS Award followed.

Provider of new and innovative treatment methods and products in urology, coloproctology and urogynecology, and a partner for surgeons seeking product development and patent brokering.

• EndoGYNious

  Y-shaped mesh for sacrocolpopexy and sacrocervicopexy, intended for the surgical treatment of symptomatic pelvic organ prolapse (POP) in the apical compartment, and, if present, in combination with anterior and/or posterior compartments. It is an ultralight, monofilament, polypropylene mesh with hexagonal structure, implanted via laparoscopic or transabdominal (open surgery) approach.

• A.M.I. HAL system

  System for the HAL method, offering a new, efficient and pain-free approach to treating hemorrhoidal disease.

• ATOMS system

  System introduced for the treatment of male urinary incontinence.

• Anal Band implant

  Implant for the treatment of Fecal Incontinence.

1. 1EndoGYNious - A.M.I. – Agency for Medical Innovationsami.at
2. 2Company history - A.M.I. – Agency for Medical Innovationsami.at
3. 3Medical Products - A.M.I. – Agency for Medical Innovationsami.at
4. 4Agency for Medical Innovationswikidata.org